Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The second trial, conducted at Peking University Third Hospital (Ethical code: D2020188), was a Phase I clinical triala randomized, double-blind, controlled study aimed at assessing the safety and preliminary efficacy of DPSC therapy at varying dose concentrations, carried out from July 31, 2021, to December 24, 2022
It's safe to combine glycine and magnesium supplements as long as the doses are appropriate
Ferroportin and iron regulation in breast cancer progression and prognosis
Common side effects (minimal) Most people: No side effects GHK-Cu extremely well-tolerated Natural peptide (found in body) Minimal adverse effects Possible minor effects: Injection site stinging (common, harmless) Minor bruising at injection sites Slight blue tint to injection site (copper, temporary) Mild headache (rare) Managing side effects: Stinging: Inject slowly, warm peptide to room temp Bruising: Rotate sites, proper technique Blue tint: Normal, fades within days Headache: Hydrate well, reduce dose Contraindications and cautions Avoid if: Pregnancy or breastfeeding (no data) Active cancer (theoretical copper concerns) Wilson's disease (copper metabolism disorder) Hemochromatosis (iron overload, copper caution) Use caution with: Copper supplements (avoid taking both) High copper foods (monitor intake) Liver disease (copper metabolism) Generally safe for: All ages (adults) Men and women Long-term use Most health conditions Copper toxicity concerns Is copper in GHK-Cu dangerous
Our other brands
Supports skin that looks smoother and more refined with consistent nightly use
